№ lp_2_3_27530
File format: docx Character count: 16155 File size: 43 KB
Comprehensive academic and professional curriculum vitae detailing Dr. Udeme Ekrikpo’s education, medical training, clinical appointments, research contributions, committee memberships, and awards in the field of nephrology and internal medicine.
Name: Dr. Udeme Ekrikpo
Date of birth: 18 October 1977
Sex: Male
Nationality: Nigerian
Education: Primary, Secondary, University of Ibadan (M.B; B.S.), M.Sc. Epidemiology and Biostatistics, Advanced PGD Healthcare & Hospital Management, Ph.D. Nephrology (University of Cape Town)
Professional experience: Anatomy Demonstrator, Medical Director, Registrar and Senior Registrar in Internal Medicine and Nephrology, Lecturer and Senior Lecturer, Deputy Director Institute of Health Research and Development
Awards: Dr Ola’s Prize in Pathology and Pharmacology, Prof. B.O. Osuntokun’s Prize in Medicine, Departmental prizes, NYSC Abia State Merit Award, West African College of Physicians primaries, FMCP Internal Medicine, Fellowship National Postgraduate Medical College, Bayer Foundation Fellowship, Rotary Club of Uyo award, Best Poster at South African Renal Congress
Committee memberships: Antiretroviral Treatment Review Committee, Dialysis and Consumables Fund Committee, National Renal Registry Committee, Infectious Disease Research Committee, Chair of Scientific and CPD/CME Committees, Examinations Officer, Residency Training Coordinator
Research and publications: Multiple peer-reviewed articles in nephrology, internal medicine, HIV-related nephropathy, hypertension, echocardiography, and public health studies in Nigeria and Africa
Professional recognition: InterAcademy Medical Panel Young Physician Leader (2013), Contributor to Times Higher Education World University Ranking, Peer Reviewer for Haemodialysis International and Nigerian Journal of Clinical Practice
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Guidelines for Authors of The Japanese Journal of Nephrology and Pharmacotherapy (JJNP), Effective December 1, 2011 (Revised through February 28, 2020)
Journal: The Japanese Journal of Nephrology and Pharmacotherapy (JJNP)
Issuing organization: Japanese Society of Nephrology and Pharmacotherapy
Field: Nephrology and Pharmacotherapy
Document type: Author guidelines
Effective date: December 1, 2011
Revision dates: February 1, 2012; March 23, 2012; April 4, 2012; May 11, 2012; May 15, 2012; June 5, 2012; October 12, 2013; October 25, 2013; June 13, 2014; May 1, 2016; July 1, 2016; July 1, 2017; February 28, 2020
Submission language: Japanese or English
Peer review system: Multiple peer review system (two or more reviewers)
Ethical standards: Helsinki Declaration; Ethical Guidelines for Medical and Health Research Involving Human Subjects (MHLW); Ethical Guidelines for Human Genome/Gene Analysis Research (MHLW); Fundamental Guidelines for Proper Conduct of Animal Experiments and Related Activities in Academic Research Institutions (MEXT)
Conflict of interest policy: Disclosure required in accordance with JJNP Guidelines for Conflict of Interest
Copyright: Transferred to JSNP upon acceptance
Publication fees: No publication charge; manuscript fees and reprint charges as specified
Administrative office: Japanese Society of Nephrology and Pharmacotherapy Administrative Office, Mainichi Academic Forum, Tokyo, Japan
Patient Information: Lanthanum (Fosrenol®) – Nephrology Department (V1: 08/2017)
Department: Nephrology Department
Document type: Patient information leaflet
Medication name: Lanthanum (Fosrenol®)
Pharmacological class: Phosphate binder
Indication: Hyperphosphataemia in patients with impaired kidney function
Version: V1
Date: 08/2017
Author: Emma Head
Author role: Renal Advanced Nurse Practitioner
Contact telephone: 01553 613076
Contact availability: Monday – Friday, 8:30am until 2pm
Monitoring: Regular blood phosphate level checks at renal clinic
Administration instructions: To be taken towards the end of meals, chewed before swallowing
Known side effects: Constipation, diarrhoea, sickness
Drug interactions: Iron tablets and certain antibiotics
Topics: Udeme Ekrikpo Nephrology